Your browser doesn't support javascript.
loading
Correlation of serum angiopoietin-1, angiopoietin-2, and angiopoietin-1/angiopoietin-2 ratio with HBV DNA and alanine aminotransferase in patients with chronic hepatitis B or liver cirrhosis / 临床肝胆病杂志
Journal of Clinical Hepatology ; (12): 1126-1129, 2024.
Article em Zh | WPRIM | ID: wpr-1032259
Biblioteca responsável: WPRO
ABSTRACT
ObjectiveTo investigate the correlation of serum angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and Ang-1/Ang-2 ratio with HBA DNA and alanine aminotransferase (ALT) in patients with chronic hepatitis B (CHB) or liver cirrhosis. MethodsClinical data and serum specimens were collected from 99 patients with CHB and 59 patients with liver cirrhosis who were admitted to Beijing YouAn Hospital, Capital Medical University, from March 2018 to October 2019, and 46 individuals who underwent physical examination were enrolled as control group. PCR was used to measure serum HBV DNA level, and ELISA was used to measure the serum levels of Ang-1 and Ang-2. The serum levels of Ang-1 and Ang-2 and Ang-1/Ang-2 ratio were compared between groups. The Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups, and the Bonferroni method was used for further comparison between two groups; the Spearman correlation analysis was used to investigate the correlation of Ang-1, Ang-2, and Ang-1/Ang-2 ratio with HBV DNA and ALT. ResultsCompared with the control group, the CHB group and the liver cirrhosis group had a significant reduction in the level of Ang-1 (479.0 pg/mL and 208.4 pg/mL vs 671.0 pg/mL, both P<0.05), and compared with the CHB group, the liver cirrhosis group had a significant reduction in the level of Ang-1 (P<0.001). Compared with the control group, the CHB group and the liver cirrhosis group had a significant increase in the level of Ang-2 (286.1 pg/mL and 438.4 pg/mL vs 198.0 pg/mL, both P<0.001), and compared with the CHB group, the liver cirrhosis group had a significant increase in the level of Ang-2 (P<0.001). Compared with the control group, the CHB group and the liver cirrhosis group had a significant reduction in Ang-1/Ang-2 ratio (1.6 and 0.5 vs 3.4, both P<0.001), and compared with the CHB group, the liver cirrhosis group had a significant reduction in Ang-1/Ang-2 ratio (P<0.001). The Spearman correlation analysis showed that in the CHB group, Ang-1 was negatively correlated with HBV DNA and ALT (r=-0.400 and -0.394, both P˂0.001), Ang-2 was positively correlated with HBV DNA and ALT (r=0.365 and 0.351, both P<0.001), and Ang-1/Ang-2 ratio was negatively correlated with HBV DNA and ALT (r=-0.463 and -0.473, both P<0.001); in the liver cirrhosis group, Ang-1, Ang-2, and Ang-1/Ang-2 ratio had no correlation with HBV DNA or ALT (all P>0.05). ConclusionThere are significant changes in the serum levels of Ang-1 and Ang-2 and Ang-1/Ang-2 ratio in patients with CHB or liver cirrhosis, and Ang-1, Ang-2, and Ang-1/Ang-2 ratio reflects the degree of liver injury in patients with CHB to a certain extent.
Palavras-chave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Journal of Clinical Hepatology Ano de publicação: 2024 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Journal of Clinical Hepatology Ano de publicação: 2024 Tipo de documento: Article